European Lung Cancer Congress 2024: ESMO Colloquia
The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and educational programme of the Congress. The industry has no influence on the content of the programme or speaker selection. All ESMO Colloquia are open to multi-sponsor support and interested sponsors can contact ESMO for more information on future programmes at colloquia@esmo.org.
View the complete ELCC 2024 programme online
Optimising molecular diagnosis and precision therapy in patients with advanced NSCLC harbouring rare oncogenic translocations
Wednesday, 20 March 2024
18:15-19:45 CET (Central European Time)
Forum Hall
This educational activity is provided by ESMO and supported by Eli Lilly and Company.
View the ESMO colloquium details
Learning Objectives
- To inform on molecular diagnostics, its implementation and interpretation for patients with advanced NSCLC
- To update on precision therapeutics for treatment-naive patients with advanced NSCLC harbouring rare oncogenic translocations
- To provide insights on mechanisms of resistance